α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 21, Pages 17065-17076
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-03-29
DOI
10.1074/jbc.m112.349365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- (2011) P N Kelly et al. CELL DEATH AND DIFFERENTIATION
- Irradiated mesenchymal stem cells improve the ex vivo expansion of hematopoietic progenitors by partly mimicking the bone marrow endosteal environment
- (2011) Betül Çelebi et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment
- (2011) M Ishihara et al. LEUKEMIA
- Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells
- (2010) Nuria López-Royuela et al. BIOCHEMICAL PHARMACOLOGY
- α9β1 integrin engagement inhibits neutrophil spontaneous apoptosis: Involvement of Bcl-2 family members
- (2010) Roberta F. Saldanha-Gama et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Bcl-2 proteins and mitochondria—Specificity in membrane targeting for death
- (2010) Jennefer Lindsay et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth
- (2010) F. Bouchard et al. BLOOD
- Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers
- (2010) S. Pillozzi et al. BLOOD
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study
- (2010) Amanda L Cleaver et al. Molecular Cancer
- Extracellular matrix-induced transforming growth factor-β receptor signaling dynamics
- (2010) N Garamszegi et al. ONCOGENE
- Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents
- (2009) T Sánchez-Pérez et al. CELL DEATH AND DIFFERENTIATION
- Down-regulation of Notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy
- (2009) Dongmei Guo et al. LEUKEMIA & LYMPHOMA
- Extracellular Matrix-Induced Gene Expression in Human Breast Cancer Cells
- (2009) N. Garamszegi et al. MOLECULAR CANCER RESEARCH
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Cell-autonomous requirement for 1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice
- (2008) T. R. Carlson et al. DEVELOPMENT
- Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation
- (2008) Min H. Kang et al. JNCI-Journal of the National Cancer Institute
- Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis
- (2008) N. Chetoui et al. MOLECULAR CANCER RESEARCH
- Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
- (2008) E. Weisberg et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation